Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
Scientific Reports
|
February 15, 2024
A pan-influenza monoclonal antibody neutralizes H5 strains and prophylactically protects through intranasal administration
Anna L Beukenhorst, Jacopo Frallicciardi, Keira L Rice, et al.
Cell Host & Microbe
|
May 21, 2009
The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progression
Nicole M Walley, Boris Julg, Samuel P Dickson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 12, 2009
Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa
Zabrina Brumme, Bingxia Wang, Kriebashne Nair, et al.
Cell Host & Microbe
|
September 13, 2019
A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge
Amarendra Pegu, Bhavesh Borate, Yunda Huang, et al.
Plos Pathogens
|
August 29, 2014
Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individuals
Nichole R Klatt, Steven E Bosinger, Melicent Peck, et al.
Science Translational Medicine
|
February 4, 2026
Phase 1 and preclinical studies reveal safety, pharmacokinetics, and efficacy of intranasal delivery of the influenza antibody CR9114
Anna L Beukenhorst, Robin Rogiers, Keira L Rice, et al.
Med (New York, N.Y.)
|
November 19, 2025
Epstein-Barr-virus-specific functional antibody signatures in the context of nasopharyngeal carcinoma development
Vicky Roy, Benjamin P Kellman, Wan-Lun Hsu, et al.
Science Translational Medicine
|
September 22, 2017
Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail
Boris Julg, Po-Ting Liu, Kshitij Wagh, et al.
Nature Communications
|
January 30, 2024
Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccination
Nadège Nziza, Yixiang Deng, Lianna Wood, et al.
Circulation
|
January 4, 2023
Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis
Lael M Yonker, Zoe Swank, Yannic C Bartsch, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
Scientific Reports
|
February 15, 2024
A pan-influenza monoclonal antibody neutralizes H5 strains and prophylactically protects through intranasal administration
Anna L Beukenhorst, Jacopo Frallicciardi, Keira L Rice, et al.
Cell Host & Microbe
|
May 21, 2009
The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progression
Nicole M Walley, Boris Julg, Samuel P Dickson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 12, 2009
Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa
Zabrina Brumme, Bingxia Wang, Kriebashne Nair, et al.
Cell Host & Microbe
|
September 13, 2019
A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge
Amarendra Pegu, Bhavesh Borate, Yunda Huang, et al.
Plos Pathogens
|
August 29, 2014
Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individuals
Nichole R Klatt, Steven E Bosinger, Melicent Peck, et al.
Science Translational Medicine
|
February 4, 2026
Phase 1 and preclinical studies reveal safety, pharmacokinetics, and efficacy of intranasal delivery of the influenza antibody CR9114
Anna L Beukenhorst, Robin Rogiers, Keira L Rice, et al.
Med (New York, N.Y.)
|
November 19, 2025
Epstein-Barr-virus-specific functional antibody signatures in the context of nasopharyngeal carcinoma development
Vicky Roy, Benjamin P Kellman, Wan-Lun Hsu, et al.
Science Translational Medicine
|
September 22, 2017
Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail
Boris Julg, Po-Ting Liu, Kshitij Wagh, et al.
Nature Communications
|
January 30, 2024
Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccination
Nadège Nziza, Yixiang Deng, Lianna Wood, et al.
Circulation
|
January 4, 2023
Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis
Lael M Yonker, Zoe Swank, Yannic C Bartsch, et al.
Page
of 7